PACTR202112686695509尚未招募4 期
Effectiveness of adding nitazoxanide to the standard triple therapy in the eradication of Helicobacter pylori infection
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- o
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Any Naive Patient above the age of 18 years old with H.pylori infection will be included in the study. Patients infected by H.pylori will be diagnosed by stool antigen test.
排除标准
- •Patients aged less than 18 years, prior gastric surgery, Prior H. pylori eradication therapy, recent intake of antibiotics, proton pump inhibitor (PPI), histamine (H2) receptor blockers, nonsteroidal or anti-inflammatory drugs within the last month, known allergy of any of the antibiotics used in the study, gastrointestinal malignancy, active upper gastrointestinal bleeding, pregnant and lactating women will be excluded from the study.
研究者
相似试验
已完成
4 期
A study to determine whether drug Nitazoxanide is useful in uncomplicated amoebic liver abscessCTRI/2019/01/017249Vasudha Goel92
已完成
不适用
To compare the efficacy of Nitazoxanide in a single dose of 3g VO and metronidazole in a single dose of 2g in the eradication of T. vaginalis.Trichomoniasis-A59 TrichomoniasisA59PER-009-02ASOCIACION BENEFICA PRISMA,
招募中
2 期
Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19Coronavirus infection, unspecified / COVID-19B34.2RBR-4nr86mniversidade Federal do Rio de Janeiro-UFRJ
已完成
2 期
Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in ChildrenViral Gastroenteritis Due to RotavirusRotavirus InfectionNCT01328925Romark Laboratories L.C.100
已完成
3 期
Nitazoxanide for the Treatment of Prolonged Diarrhea in ChildrenDiarrheaNCT01326338Romark Laboratories L.C.100